Table 1.
Descriptive analysis of the 57 families studied at the Department of Women’s and Children’s Health of the University Hospital of Padova (Italy).
| Overall | Children/older siblings | Parents | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-COVID-19 | COVID-19 | p-value § | Non-COVID-19 | COVID-19 | p-value § | Non-COVID-19 | COVID-19 | p-value § | |
| (n = 54) | (n = 152) | (n = 30) | (n = 70) | (n = 24) | (n = 82) | ||||
| Female n (%) | 23 (42.6%) | 78 (51.3%) | 0.27 | 12 (40%) | 33 (47.1%) | 0.51 | 11 (45.8%) | 45 (54.9%) | 0.44 |
| Age Median (IQR) | 15.6 (4.5–41.6) | 28.6 (8.2–42.1) | 0.33 | 5.4 (3.2–8.8) | 8 (4.3–12.6) | 0.21 | 42.1 (38.7–45.3) | 41.7 (33.5–46.5) | 0.13 |
| Age classes n (%) | |||||||||
| <6 years | 15 (27.8%) | 27 (17.8%) | 0.24 | 15 (50%) | 27 (38.6%) | 0.52 | – | – | |
| 6≤ age <15 | 12 (22.2%) | 32 (21.1%) | 12 (40%) | 32 (45.7%) | – | – | |||
| ≥15 years | 27 (50%) | 93 (61.2%) | 3 (10%) | 11 (15.7%) | 24 (100%) | 82 (100%) | |||
| WHO classification* n (%) | |||||||||
| Asymptomatic | – | 25 (16.5%) | – | 16 (22.9%) | – | 10 (12.2%) | |||
| Mild | – | 119 (78.3%) | – | 53 (75.7%) | – | 65 (79.3%) | |||
| Moderate | – | 6 (4%) | – | 1 (1.4%) | – | 5 (6.1%) | |||
| Severe | – | 1 (0.7%) | – | 0 (0%) | – | 1 (1.2%) | |||
| Critical | – | 1 (0.7%) | – | 0 (0%) | – | 1 (1.2%) | |||
| Pediatric comorbidities n (%) | |||||||||
| No | – | – | 27 (90%) | 54 (77.1%) | 0.13 | – | – | ||
| Yes** | – | – | 3 (10%) | 16 (22.9%) | – | – | |||
§Student’s t-test, χ2 test, Fisher exact test where appropriate.
*WHO, World Health Organization.
**The following co-morbidities were found among 16 COVID-19 positive children: premature birth (n = 1), asthma (n = 5), allergy (n = 1), congenital heart disease (n = 1), rheumatic disease (n = 1), chronic neuropathy (n = 1), immune deficiency (n = 2), cleft lip and palate (n = 1), and kidney/ureteral disease (n = 1).